Cinar P - Search Results

1

Metastatic Pancreatic Cancer: ASCO Guideline Update.

Sohal DPS, Kennedy EB, Cinar P, Conroy T, Copur MS, Crane CH, Garrido-Laguna I, Lau MW, Johnson T, Krishnamurthi S, Moravek C, O'Reilly EM, Philip PA, Pant S, Shah MA, Sahai V, Uronis HE, Zaidi N, Laheru D. Sohal DPS, et al. Among authors: cinar p. J Clin Oncol. 2020 Sep 20;38(27):3217-3230. doi: 10.1200/JCO.20.01364. Epub 2020 Aug 5. J Clin Oncol. 2020. PMID: 32755482

2

CA 19-9 Response: A Surrogate to Predict Survival in Patients With Metastatic Pancreatic Adenocarcinoma.

Diaz CL, Cinar P, Hwang J, Ko AH, Tempero MA. Diaz CL, et al. Among authors: cinar p. Am J Clin Oncol. 2019 Dec;42(12):898-902. doi: 10.1097/COC.0000000000000620. Am J Clin Oncol. 2019. PMID: 31634155

3

Multidisciplinary Management of Pancreatic Cancer.

Cinar P, Zendejas P. Cinar P, et al. J Adv Pract Oncol. 2022 Apr;13(3):311-314. doi: 10.6004/jadpro.2022.13.3.26. Epub 2022 May 23. J Adv Pract Oncol. 2022. PMID: 35663188 Free PMC article.

4

Monoclonal antibodies and other targeted therapies for pancreatic cancer.

Cinar P, Tempero MA. Cinar P, et al. Cancer J. 2012 Nov-Dec;18(6):653-64. doi: 10.1097/PPO.0b013e3182758985. Cancer J. 2012. PMID: 23187854 Review.

5

Best practices for the treatment of metastatic pancreatic adenocarcinoma: the therapeutic landscape in 2017.

Cinar P, Ko AH. Cinar P, et al. Chin Clin Oncol. 2017 Jun;6(3):29. doi: 10.21037/cco.2017.06.13. Chin Clin Oncol. 2017. PMID: 28705006 Free article. Review.

6

Safety at the Time of the COVID-19 Pandemic: How to Keep our Oncology Patients and Healthcare Workers Safe.

Cinar P, Kubal T, Freifeld A, Mishra A, Shulman L, Bachman J, Fonseca R, Uronis H, Klemanski D, Slusser K, Lunning M, Liu C. Cinar P, et al. J Natl Compr Canc Netw. 2020 Apr 15:1-6. doi: 10.6004/jnccn.2020.7572. Online ahead of print. J Natl Compr Canc Netw. 2020. PMID: 32294617

7

Survival for patients with invasive cutaneous melanoma among ethnic groups: the effects of socioeconomic status and treatment.

Zell JA, Cinar P, Mobasher M, Ziogas A, Meyskens FL Jr, Anton-Culver H. Zell JA, et al. Among authors: cinar p. J Clin Oncol. 2008 Jan 1;26(1):66-75. doi: 10.1200/JCO.2007.12.3604. J Clin Oncol. 2008. PMID: 18165642

8

Evolving treatment options for locally advanced unresectable pancreatic ductal adenocarcinoma.

Cinar P, Ko AH. Cinar P, et al. J Natl Compr Canc Netw. 2014 Feb;12(2):167-72. doi: 10.6004/jnccn.2014.0017. J Natl Compr Canc Netw. 2014. PMID: 24586078

9

Implementation of an Embedded In-Clinic Genetic Testing Station to Optimize Germline Testing for Patients with Pancreatic Adenocarcinoma.

Walker EJ, Goldberg D, Gordon KM, Pedley C, Carnevale J, Cinar P, Collisson EA, Tempero MA, Ko AH, Blanco AM, Dhawan M. Walker EJ, et al. Among authors: cinar p. Oncologist. 2021 Nov;26(11):e1982-e1991. doi: 10.1002/onco.13968. Epub 2021 Sep 20. Oncologist. 2021. PMID: 34506673 Free PMC article.

10

Early Response Assessment in Pancreatic Ductal Adenocarcinoma Through Integrated PET/MRI.

Wang ZJ, Behr S, Consunji MV, Yeh BM, Ohliger MA, Gao K, Ko AH, Cinar P, Tempero MA, Collisson EA. Wang ZJ, et al. Among authors: cinar p. AJR Am J Roentgenol. 2018 Nov;211(5):1010-1019. doi: 10.2214/AJR.18.19602. Epub 2018 Jul 31. AJR Am J Roentgenol. 2018. PMID: 30063366

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

26 results

Search Page